STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -75.0% | 300 | -76.9% | 0.00% | -100.0% |
| Q4 2018 | $12,000 | -42.9% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $21,000 | +5.0% | 1,300 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $20,000 | -31.0% | 1,300 | -83.1% | 0.00% | -33.3% |
| Q1 2018 | $29,000 | -43.1% | 7,700 | +1.3% | 0.00% | +50.0% |
| Q4 2017 | $51,000 | +45.7% | 7,600 | -24.0% | 0.00% | +100.0% |
| Q3 2017 | $35,000 | +6.1% | 10,000 | -18.7% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | +37.5% | 12,300 | +84.4% | 0.00% | 0.0% |
| Q1 2017 | $24,000 | -69.6% | 6,670 | -46.3% | 0.00% | -66.7% |
| Q4 2016 | $79,000 | +49.1% | 12,416 | +2.2% | 0.00% | 0.0% |
| Q3 2016 | $53,000 | +140.9% | 12,146 | +52.9% | 0.00% | +200.0% |
| Q2 2016 | $22,000 | 0.0% | 7,946 | +67.4% | 0.00% | 0.0% |
| Q1 2016 | $22,000 | -33.3% | 4,746 | -12.9% | 0.00% | -50.0% |
| Q4 2015 | $33,000 | – | 5,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |